Literature DB >> 12591177

AT4 receptor is insulin-regulated membrane aminopeptidase: potential mechanisms of memory enhancement.

Anthony L Albiston1, Tomris Mustafa, Sharon G McDowall, Frederick A O Mendelsohn, Joohyung Lee, Siew Yeen Chai.   

Abstract

Although angiotensin IV (Ang IV) was thought initially to be an inactive product of Ang II degradation, it was subsequently shown that the hexapeptide markedly enhances learning and memory in normal rodents and reverses the memory deficits seen in animal models of amnesia. These central nervous system effects of Ang IV are mediated by binding to a specific site, known as the AT(4) receptor, which is found in appreciable levels throughout the brain and is concentrated particularly in regions involved in cognition. This field of research was redefined by the identification of the AT(4) receptor as the transmembrane enzyme, insulin-regulated membrane aminopeptidase (IRAP). Here, we explore the potential mechanisms by which Ang IV binding to IRAP leads to the facilitation of learning and memory.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591177     DOI: 10.1016/s1043-2760(02)00037-1

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  21 in total

Review 1.  The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Authors:  John W Wright; Joseph W Harding
Journal:  Pflugers Arch       Date:  2012-04-26       Impact factor: 3.657

2.  Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.

Authors:  Chad E Beyer; Jason M Dwyer; Brian J Platt; Sarah Neal; Bin Luo; Huai-Ping Ling; Qian Lin; Robert J Mark; Sharon Rosenzweig-Lipson; Lee E Schechter
Journal:  Psychopharmacology (Berl)       Date:  2010-03-12       Impact factor: 4.530

Review 3.  Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.

Authors:  Jessika Royea; Edith Hamel
Journal:  Geroscience       Date:  2020-07-22       Impact factor: 7.713

Review 4.  Methods of Measuring Enzyme Activity Ex Vivo and In Vivo.

Authors:  Yangguang Ou; Rachael E Wilson; Stephen G Weber
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2018-03-05       Impact factor: 10.745

5.  Insulin-regulated aminopeptidase is a key regulator of GLUT4 trafficking by controlling the sorting of GLUT4 from endosomes to specialized insulin-regulated vesicles.

Authors:  Ingrid Jordens; Dorothee Molle; Wenyong Xiong; Susanna R Keller; Timothy E McGraw
Journal:  Mol Biol Cell       Date:  2010-04-21       Impact factor: 4.138

Review 6.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

Review 7.  Aminopeptidase A inhibitors as centrally acting antihypertensive agents.

Authors:  Laurence Bodineau; Alain Frugière; Yannick Marc; Cédric Claperon; Catherine Llorens-Cortes
Journal:  Heart Fail Rev       Date:  2008-01-03       Impact factor: 4.214

8.  Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells.

Authors:  J Longden; E-L Cooke; S J Hill
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

Review 9.  Cognitive-enhancing effects of angiotensin IV.

Authors:  Paul R Gard
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

10.  Trans-Modulation of the Somatostatin Type 2A Receptor Trafficking by Insulin-Regulated Aminopeptidase Decreases Limbic Seizures.

Authors:  Dimitri De Bundel; Assia Fafouri; Zsolt Csaba; Ellen Loyens; Sophie Lebon; Vincent El Ghouzzi; Stéphane Peineau; Guilan Vodjdani; Foteini Kiagiadaki; Najat Aourz; Jessica Coppens; Laura Walrave; Jeanelle Portelli; Patrick Vanderheyden; Siew Yeen Chai; Kyriaki Thermos; Véronique Bernard; Graham Collingridge; Stéphane Auvin; Pierre Gressens; Ilse Smolders; Pascal Dournaud
Journal:  J Neurosci       Date:  2015-08-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.